Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth - PubMed (original) (raw)
Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth
Michele W L Teng et al. Cancer Res. 2010.
Erratum in
- Cancer Res. 2010 Dec 1;70(23):10014
Abstract
Foxp3 is a central control element in the development and function of regulatory T cells (Treg), and mice expressing a diphtheria toxin (DT) receptor-enhanced green fluorescent protein fusion protein under the control of the foxp3 gene locus (DEREG mice) allow conditional and efficient depletion of Foxp3(+) Treg by DT injection. Herein, we use DEREG mice and a mouse model of carcinogenesis to show that conditional and effective Treg depletion can both protect mice from carcinogenesis by innate control, yet permanently eradicate a proportion of de novo-established tumors in mice in a largely CD8(+) T-cell- and IFN-γ-dependent manner. Tumors displayed a heterogeneous response to Treg depletion, and suppression of established tumors was accompanied by an increase in the tumor-infiltrating CD8(+) T-cell/B-cell ratio. Tumor rejection occurred in the absence of overt autoimmunity, suggesting that effective transient Treg depletion strategies may be therapeutic in at least a proportion of spontaneous tumors developing in the host.
©2010 AACR.
Similar articles
- Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
Klages K, Mayer CT, Lahl K, Loddenkemper C, Teng MW, Ngiow SF, Smyth MJ, Hamann A, Huehn J, Sparwasser T. Klages K, et al. Cancer Res. 2010 Oct 15;70(20):7788-99. doi: 10.1158/0008-5472.CAN-10-1736. Epub 2010 Oct 5. Cancer Res. 2010. PMID: 20924102 - Efficient Treg depletion induces T-cell infiltration and rejection of large tumors.
Li X, Kostareli E, Suffner J, Garbi N, Hämmerling GJ. Li X, et al. Eur J Immunol. 2010 Dec;40(12):3325-35. doi: 10.1002/eji.201041093. Eur J Immunol. 2010. PMID: 21072887 - Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.
Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, Sparwasser T. Lahl K, et al. J Exp Med. 2007 Jan 22;204(1):57-63. doi: 10.1084/jem.20061852. Epub 2007 Jan 2. J Exp Med. 2007. PMID: 17200412 Free PMC article. - The significance of Treg cells in defective tumor immunity.
Kosmaczewska A, Ciszak L, Potoczek S, Frydecka I. Kosmaczewska A, et al. Arch Immunol Ther Exp (Warsz). 2008 May-Jun;56(3):181-91. doi: 10.1007/s00005-008-0018-1. Epub 2008 May 30. Arch Immunol Ther Exp (Warsz). 2008. PMID: 18512029 Review. - Differentiation, cancer, and anticancer activity.
Tzen CY, Estervig DN, Minoo P, Filipak M, Maercklein PB, Hoerl BJ, Scott RE. Tzen CY, et al. Biochem Cell Biol. 1988 Jun;66(6):478-89. doi: 10.1139/o88-060. Biochem Cell Biol. 1988. PMID: 3048326 Review.
Cited by
- Peripheral-derived regulatory T cells contribute to tumor-mediated immune suppression in a nonredundant manner.
Hossain MM, King P, Hackett J, Gerard HC, Niwinski R, Wu L, Van Kaer L, Dyson G, Gibson H, Borowsky AD, Sebzda E. Hossain MM, et al. Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2404916121. doi: 10.1073/pnas.2404916121. Epub 2024 Aug 29. Proc Natl Acad Sci U S A. 2024. PMID: 39207730 - The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues.
Panek WK, Toedebusch RG, Mclaughlin BE, Dickinson PJ, Van Dyke JE, Woolard KD, Berens ME, Lesniak MS, Sturges BK, Vernau KM, Li C, Miska J, Toedebusch CM. Panek WK, et al. J Neurooncol. 2024 Sep;169(3):647-658. doi: 10.1007/s11060-024-04766-4. Epub 2024 Jul 24. J Neurooncol. 2024. PMID: 39046599 Free PMC article. - IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy.
Imianowski CJ, Kuo P, Whiteside SK, von Linde T, Wesolowski AJ, Conti AG, Evans AC, Baird T, Morris BI, Fletcher NE, Yang J, Poon E, Lakins MA, Yamamoto M, Brewis N, Morrow M, Roychoudhuri R. Imianowski CJ, et al. Cancer Res Commun. 2024 Aug 1;4(8):2045-2057. doi: 10.1158/2767-9764.CRC-23-0500. Cancer Res Commun. 2024. PMID: 38995700 Free PMC article. - The CCL2-CCR4 Axis Promotes Regulatory T Cell Trafficking to Canine Glioma Tissues.
Panek WK, Toedebusch RG, Mclaughlin BE, Dickinson PJ, Dyke JE, Woolard KD, Berens ME, Lesniak MS, Sturges BK, Vernau KM, Li C, Miska JM, Toedebusch CM. Panek WK, et al. Res Sq [Preprint]. 2024 Jun 17:rs.3.rs-4474288. doi: 10.21203/rs.3.rs-4474288/v1. Res Sq. 2024. PMID: 38947002 Free PMC article. Updated. Preprint. - Reprogramming the tumor microenvironment with biotechnology.
Kim M, Lee NK, Wang CJ, Lim J, Byun MJ, Kim TH, Park W, Park DH, Kim SN, Park CG. Kim M, et al. Biomater Res. 2023 Jan 31;27(1):5. doi: 10.1186/s40824-023-00343-4. Biomater Res. 2023. PMID: 36721212 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials